{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:03:11Z","timestamp":1784588591796,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08238-3","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:34:36Z","timestamp":1779122076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["METTL3-driven m6A modification promotes tumor progression and immune evasion in hypoxic pancreatic cancer by enhancing ADAM10-mediated MICA shedding"],"prefix":"10.1186","volume":"24","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yebin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"8238_CR1","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"JX Hu","year":"2021","unstructured":"Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27:4298\u2013321.","journal-title":"World J Gastroenterol"},{"key":"8238_CR2","doi-asserted-by":"crossref","unstructured":"Bazeed AY, Day CM, Garg S. Pancreatic cancer: challenges and opportunities in locoregional therapies. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14174257"},{"key":"8238_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321\u201330.","journal-title":"Nature"},{"key":"8238_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrc.2017.117","volume":"18","author":"S Spranger","year":"2018","unstructured":"Spranger S, Gajewski TF. Impact of oncogenic pathways on evasion of antitumour immune responses. Nat Rev Cancer. 2018;18:139\u201347.","journal-title":"Nat Rev Cancer"},{"key":"8238_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/ijo.2013.2156","volume":"44","author":"Z Dambrauskas","year":"2014","unstructured":"Dambrauskas Z, Svensson H, Joshi M, Hyltander A, Naredi P, Iresjo BM. Expression of major histocompatibility complex class I-related chain A\/B (MICA\/B) in pancreatic carcinoma. Int J Oncol. 2014;44:99\u2013104.","journal-title":"Int J Oncol"},{"key":"8238_CR6","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","volume":"169","author":"HR Salih","year":"2002","unstructured":"Salih HR, Rammensee HG, Steinle A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol. 2002;169:4098\u2013102.","journal-title":"J Immunol"},{"key":"8238_CR7","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","volume":"68","author":"I Waldhauer","year":"2008","unstructured":"Waldhauer I, Goehlsdorf D, Gieseke F, Weinschenk T, Wittenbrink M, Ludwig A, Stevanovic S, Rammensee HG, Steinle A. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 2008;68:6368\u201376.","journal-title":"Cancer Res"},{"key":"8238_CR8","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nature01112","volume":"419","author":"V Groh","year":"2002","unstructured":"Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002;419:734\u20138.","journal-title":"Nature"},{"key":"8238_CR9","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.3892\/mmr.2015.3144","volume":"11","author":"Y Lu","year":"2015","unstructured":"Lu Y, Hu J, Sun W, Duan X, Chen X. Hypoxia-mediated immune evasion of pancreatic carcinoma cells. Mol Med Rep. 2015;11:3666\u201372.","journal-title":"Mol Med Rep"},{"key":"8238_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1242\/bio.021774","volume":"6","author":"Y Lu","year":"2017","unstructured":"Lu Y, Ji N, Wei W, Sun W, Gong X, Wang X. MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1alpha) in the tumor microenvironments. Biol Open. 2017;6:252\u20139.","journal-title":"Biol Open"},{"key":"8238_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12935-020-01370-0","volume":"20","author":"X Jin","year":"2020","unstructured":"Jin X, Dai L, Ma Y, Wang J, Liu Z. Implications of HIF-1alpha in the tumorigenesis and progression of pancreatic cancer. Cancer Cell Int. 2020;20:273.","journal-title":"Cancer Cell Int"},{"key":"8238_CR12","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1158\/0008-5472.CAN-11-2104","volume":"71","author":"IB Barsoum","year":"2011","unstructured":"Barsoum IB, Hamilton TK, Li X, Cotechini T, Miles EA, Siemens DR, Graham CH. Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide. Cancer Res. 2011;71:7433\u201341.","journal-title":"Cancer Res"},{"key":"8238_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00403-025-03896-7","volume":"317","author":"X Zhou","year":"2025","unstructured":"Zhou X, Li H, Xie Z. METTL3-modified exosomes from adipose-derived stem cells enhance the proliferation and migration of dermal fibroblasts by mediating m6A modification of CCNB1 mRNA. Arch Dermatol Res. 2025;317:418.","journal-title":"Arch Dermatol Res"},{"key":"8238_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2020.06.153","volume":"530","author":"N Tsuruta","year":"2020","unstructured":"Tsuruta N, Tsuchihashi K, Ohmura H, Yamaguchi K, Ito M, Ariyama H, Kusaba H, Akashi K, Baba E. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells. Biochem Biophys Res Commun. 2020;530:235\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"8238_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12943-025-02500-w","volume":"24","author":"H Chen","year":"2025","unstructured":"Chen H, Li M, Xie F, Liu S, Yang A, Yin J, Wang X, Long Y, Wu S, Cai L, et al. A novel protein cPFKFB4 encoded by hsa_circ_0065394 strengthens PKM2-mediated glucose metabolic reprogramming to facilitate pancreatic cancer progression under hypoxia. Mol Cancer. 2025;24:285.","journal-title":"Mol Cancer"},{"key":"8238_CR16","first-page":"2016","volume":"55","author":"L Badea","year":"2008","unstructured":"Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology. 2008;55:2016\u201327.","journal-title":"Hepatogastroenterology"},{"key":"8238_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/modpathol.2013.154","volume":"27","author":"M Park","year":"2014","unstructured":"Park M, Kim M, Hwang D, Park M, Kim WK, Kim SK, Shin J, Park ES, Kang CM, Paik YK, Kim H. Characterization of gene expression and activated signaling pathways in solid-pseudopapillary neoplasm of pancreas. Mod Pathol. 2014;27:580\u201393.","journal-title":"Mod Pathol"},{"key":"8238_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13073-014-0105-3","volume":"6","author":"S Haider","year":"2014","unstructured":"Haider S, Wang J, Nagano A, Desai A, Arumugam P, Dumartin L, Fitzgibbon J, Hagemann T, Marshall JF, Kocher HM, et al. A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med. 2014;6:105.","journal-title":"Genome Med"},{"key":"8238_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","volume":"15","author":"Q Wu","year":"2022","unstructured":"Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K, Adam V. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol. 2022;15:77.","journal-title":"J Hematol Oncol"},{"key":"8238_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/imm.12380","volume":"143","author":"V Kumar","year":"2014","unstructured":"Kumar V, Gabrilovich DI. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment. Immunology. 2014;143:512\u20139.","journal-title":"Immunology"},{"key":"8238_CR21","doi-asserted-by":"publisher","first-page":"880810","DOI":"10.3389\/fimmu.2022.880810","volume":"13","author":"B Janji","year":"2022","unstructured":"Janji B, Chouaib S. The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality? Front Immunol. 2022;13:880810.","journal-title":"Front Immunol"},{"key":"8238_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-020-01030-w","volume":"14","author":"J Tao","year":"2021","unstructured":"Tao J, Yang G, Zhou W, Qiu J, Chen G, Luo W, Zhao F, You L, Zheng L, Zhang T, Zhao Y. Targeting hypoxic tumor microenvironment in pancreatic cancer. J Hematol Oncol. 2021;14:14.","journal-title":"J Hematol Oncol"},{"key":"8238_CR23","first-page":"91","volume":"2","author":"A Yuen","year":"2014","unstructured":"Yuen A, Diaz B. The impact of hypoxia in pancreatic cancer invasion and metastasis. Hypoxia (Auckl). 2014;2:91\u2013106.","journal-title":"Hypoxia (Auckl)"},{"key":"8238_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2020.07.041","volume":"492","author":"VM Shah","year":"2020","unstructured":"Shah VM, Sheppard BC, Sears RC, Alani AW. Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer. Cancer Lett. 2020;492:63\u201370.","journal-title":"Cancer Lett"},{"key":"8238_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.21147\/j.issn.1000-9604.2023.03.07","volume":"35","author":"J Zhang","year":"2023","unstructured":"Zhang J, Guo F, Li L, Zhang S, Wang Y. Immune evasion and therapeutic opportunities based on natural killer cells. Chin J Cancer Res. 2023;35:283\u201398.","journal-title":"Chin J Cancer Res"},{"key":"8238_CR26","doi-asserted-by":"publisher","first-page":"910595","DOI":"10.3389\/fimmu.2022.910595","volume":"13","author":"B Seliger","year":"2022","unstructured":"Seliger B, Koehl U. Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies. Front Immunol. 2022;13:910595.","journal-title":"Front Immunol"},{"key":"8238_CR27","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.","journal-title":"Biomed Pharmacother"},{"key":"8238_CR28","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","volume":"82","author":"Z Ni","year":"2022","unstructured":"Ni Z, Sun P, Zheng J, Wu M, Yang C, Cheng M, Yin M, Cui C, Wang G, Yuan L, et al. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA. Cancer Res. 2022;82:1789\u2013802.","journal-title":"Cancer Res"},{"key":"8238_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-023-00479-4","volume":"11","author":"L Zhan","year":"2023","unstructured":"Zhan L, Zhang J, Zhang JH, Liu XJ, Guo B, Chen JH, Tang ZH, Wang WY, Wang QY, Wei B, Cao YX. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer. Biomark Res. 2023;11:43.","journal-title":"Biomark Res"},{"key":"8238_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70.","journal-title":"Signal Transduct Target Ther"},{"key":"8238_CR31","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036304","volume":"20","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao L, Li XF. Hypoxia and the Tumor Microenvironment. Technol Cancer Res Treat. 2021;20:15330338211036304.","journal-title":"Technol Cancer Res Treat"},{"key":"8238_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fimmu.2020.00044","volume":"11","author":"S Maurer","year":"2020","unstructured":"Maurer S, Kopp HG, Salih HR, Kropp KN. Modulation of Immune Responses by Platelet-Derived ADAM10. Front Immunol. 2020;11:44.","journal-title":"Front Immunol"},{"key":"8238_CR33","doi-asserted-by":"publisher","first-page":"152666","DOI":"10.1016\/j.prp.2019.152666","volume":"215","author":"T Xia","year":"2019","unstructured":"Xia T, Wu X, Cao M, Zhang P, Shi G, Zhang J, Lu Z, Wu P, Cai B, Miao Y, Jiang K. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. Pathol Res Pract. 2019;215:152666.","journal-title":"Pathol Res Pract"},{"key":"8238_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"8238_CR35","doi-asserted-by":"publisher","first-page":"114343","DOI":"10.1016\/j.biopha.2023.114343","volume":"160","author":"L Gan","year":"2023","unstructured":"Gan L, Zhao Y, Fu Y, Chen Q. The potential role of m6A modifications on immune cells and immunotherapy. Biomed Pharmacother. 2023;160:114343.","journal-title":"Biomed Pharmacother"},{"key":"8238_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.","journal-title":"Mol Cancer"},{"key":"8238_CR37","doi-asserted-by":"crossref","unstructured":"Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, Ranieri E. The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13163949"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08238-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08238-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08238-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:33:47Z","timestamp":1784586827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08238-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8238"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08238-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of Xiangya Hospital, Central South University (approval no.: 2022020460), and with the 1964 Helsinki declaration. Informed consent to participate in the study has been obtained from participants. The guidelines for the care and use of animals were approved by the Medicine Animal Welfare Committee of Xiangya Hospital, Central South University (approval no.: 2022020460).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was obtained from the participants.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that there are no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"935"}}